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ABSTRACT
 Pancreatic cancer is one of the most devastating forms of human cancer, and due to the 
lack of effective treatments, it has one of the lowest five-year survival rates among all cancers. 
Angelmarin, isolated from the medicinal plant Angelica pubescens, has showed anti-pancreatic 
cancer  activity  under  nutrient-deprived  conditions.  Recent  works  in  our  laboratory  have 
identified a novel isoprenylated coumarin compound 21,  derived from angelmarin, to exhibit 
preferential cytotoxicity against pancreatic adenocarcinoma cell line PANC-1 exclusively under 
glucose deprivation, suggesting 21 targets a pathway when glycolysis is not an option for cancer 
cell survival. In this study, the anti-proliferative mechanism of 21 was investigated. In particular, 
21 was found to increase the conversion of LC3-I to LC3-II in PANC-1, similar to the effect of 
chloroquine,  an  autophagy  inhibitor,  supporting  the  potential  mechanism  of  21  through 
chloroquine-like inhibition of autophagy. Furthermore, current results showed while chloroquine 




Statistics and Treatments for Pancreatic Cancer
Pancreatic ductal adenocarcinoma is one of the most devastating forms of human cancer. 
It is the third leading cause of cancer death in the United States. The incidence and death rates 
for pancreatic cancer are still increasing; in 2016, the American Cancer Society has estimated 
53,070 new cases and 41,780 deaths1. Moreover, pancreatic cancer has the highest mortality rate 
among all major cancers, and is also known for its early metastasis and aggressive invasion of 
surrounding  tissues.  The  overall  5-year  survival  rate  is  12-14%  for  patients  with  localized 
disease, and merely 1% for patients with distant metastasis2. It is also one of the few cancers for 
which survival  has  not  improved significantly  over  the past  40 years.  Currently,  there  is  no 
standard diagnostic instrument or established early detection method for pancreatic cancer3. If 
diagnosed early, surgical removal of the tumor provides the best chance at a definitive cure, yet 
the  5-year  survival  rate  merely  increases  to  27%.  In  addition,  only  10-20% of  patients  are 
diagnosed at a stage that is amenable to resection4. Due to the lack of recognizable symptoms 
and early detection methods, patients are usually diagnosed at late tumor stages without surgical 
therapy options5. 
Chemotherapy  or  chemotherapy  with  radiation  is  usually  the  alternative  for  patients 
whose tumor could not be removed surgically. However, pancreatic cancer is highly resistant to 
conventional  chemotherapies,  including  paclitaxel,  5-fluorouracil,  leucovorin,  doxorubicin, 
gemcitabine, Cisplatin, and platinum-based drugs6-8. The lack of effective clinical treatments for 
pancreatic cancer makes it one of the cancers with the lowest five-year survival rates, and has the 
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highest global mortality rate of nearly 98%. Therefore, it remains urgent to develop novel and 
effective therapies against pancreatic cancer.
Pancreatic Cancer Cell
Pancreatic cancer cells have been found to possess tolerance for starvation, which might 
be a reason to explain the aggressiveness of pancreatic cancer. A study in 2000 reported four 
pancreatic  cancer  cell  lines,  PANC-1,  ASPC-1,  BxPC-1,  and  KP-3  survived  under  extreme 
nutrient  deprivation (deprivation of  serum, glucose,  and amino acids)  for  48h,  while  normal 
human fibroblasts would die within 24h9. One possible molecular mechanism for such tolerance, 
as proposed by the same study, is  closely associated with the high expression of PKB/Akt9, 
which is a protein kinase that regulates cell survival and proliferation. The results suggested Akt 
could be stimulated by the deprivation of amino acids or glucose, or both9.
Elimination of this starvation-resistance could become a new strategy for caner therapy. 
Since the discovery of the tolerance of pancreatic cancer cells to nutrient deprivation, several 
research studies  have aimed to investigate  the key factors  responsible  for  the tolerance.  For 
instance,  one  study  compared  the  expression  of  Hypoxia-inducible  Factor-1α  protein  in 
pancreatic  cancer  cells  to  that  in  other  cancer  cells,  and  found  cells  with  the  constitutive 
expression of HIF-1α were more resistant to apoptosis induced by glucose deprivation10. Another 
study demonstrated the critical contribution of AMP-activated protein kinase to protect cancer 
cells from metabolic stresses under nutrient-deprived conditions11. Furthermore, a more recent 
study showed the important role of GCN2-ATF4 pathway in cancer cell tolerance of starvation12; 
ATF4 is the transcription factor that regulates the genes involved in amino acid metabolism and 
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redox homeostasis, and it is upregulated by the initiation factor kinase GCN2, which could be 
activated by glucose or amino acid deprivation.
Recently, autophagy, the degradation and recycling of nonessential cellular components, 
has been shown to sustain pancreatic cancer PANC-1 cells under extreme nutrient deprivation13-
14.  The  Baek  Lab has  demonstrated  that  autophagy inhibitors,  chloroquine  and  wortmannin, 
would  suppress  PANC-1  growth  and  induce  apoptosis,  suggesting  autophagy  has  an  anti-
apoptotic  effect13.  Furthermore,  the  Laukkarinen  Lab  has  reported  that  autophagy  has  a 
cytoprotective effect against the anticancer drugs 5-fluorouracil and gemcitabine14. In the studies 
described  herein,  we  hypothesized  that  the  preferential  cytotoxicity  of  our  lead  compound 
exclusively under nutrient-deprived conditions resulted from the inhibition of autophagy.
2. Natural Products in Medicine and Angelmarin
Natural Products as Anticancer Agents
Nature  has  provided  the  largest  treasures  for  drug  discovery,  and  has  inspired  the 
development  of  modern  medicines15-16.  The  Compendium of  Materia  Medica,  written  by  Li 
Shizhen during the Ming Dynasty, has record of 1892 entries of natural plants, animals, and 
minerals that have medicinal properties, and it is highly regarded as the most comprehensive 
medical book in the history of Chinese traditional medicine17. Youyou Tu, a Chinese woman 
doctor, won the 2015 Nobel Prize in Physiology or Medicine for her discoveries of artemisinin 
(1, Figure 1) from Artemisia annua L. (Figure 1), as a novel therapy against Malaria18. Other 
significant drugs developed from natural medicinal plants include reserpine, the antihypertensive 
agent from Rauwolfia serpentina,  ephedrine, the anti-asthma agent from Ephedra sinica,  and 
tubocurarine, the muscle relaxant from Chondrondendron and Curarea species19. 
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For  treatment  of  cancer,  natural  products  have  also  played  an  important  role.  For 
instance, Vinca alkaloids are a subset of drugs derived from the pink periwinkle Catharanthus 
roseus,  that  are  used  as  anti-cancer  treatments20.  Paclitaxel  (Taxol®,  2,  Figure  2)  is  another 
anticancer  drug isolated from the bark of  the  Pacific yew tree  Taxus brevifolia,  and is  now 
commonly used as chemotherapy against various types of cancer, including ovarian, breast, lung, 
and  pancreatic  cancers.  Since  the  discovery  of  paclitaxel,  analogues  such  as  docetaxel 
(Taxotere®, 3),  Abrazane®, and Cabazitaxel (Jevtana®, 4)  have been developed and approved 
with some significant clinical advantages19.
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Figure 1. Picture of Artemisia annua L. (Qinghao) and structure 
of Artemisinin (Qinghaosu). Pictures taken from Tu. 2011.
Artemisinin (1)
Paclitaxel (2) Docetaxel (3) Cabazitaxel (4)
Figure 2. Structures of Paclitaxel, and its analogues Docetaxel and Cabazitaxel.
Natural products have provided  inspirations  for  drug  discovery  and  development. 
However,  the limited quantities of natural  products obtainable from their  natural  sources are 
insufficient for large-scale drug production. Therefore,  after the initial  discovery of a natural 
product with clinical properties, total synthesis of the natural product becomes the challenging 
task for organic chemists. Sometimes, analogues discovered in the process of synthesizing the 
natural product offer even better medical properties than the natural product itself. In our lab, we 
are interested in investigating structural analogues of the natural product angelmarin (5, Figure 3) 
as promising anticancer agents.
Discovery of Angelmarin
In 2006, a novel natural product, angelmarin (5, Figure 3), isolated from the root of the 
medicinal  plant  Angelica  pubescens,  was  found  to  kill  pancreatic  cancer  PANC-1  cells 
preferentially under nutrition starvation. Angelmarin is composed of a columbianetin core (blue, 
Figure  3)  and  p-hydroxycinnamoyl  tail  (red,  Figure  3).  At  a  concentration  of  0.01  µg/mL, 
angelmarin induced 100% cytotoxicity against PANC-1 cells after 24h of starvation, and when 
the concentration increased to 10µg/mL, 100% cell death was observed within 6h. On the other 
hand, the structural components of angelmarin, columbianetin and p-hydroxycinnamic acid were 
both inactive in nutrient-rich and nutrient-deprived conditions, suggesting the significance of the 








Figure 3. Structure of Angelmarin, and its 
structure  components  columbianetin  core 
(blue) and p-hydroxycinnamoyl tail (red)Angelmarin (5)
3. Structure-Activity Relationship (SAR) Studies of Coumarin Derivatives
SAR Study of Hydroxycoumarin Derivatives
Structure-Activity  Relationship  (SAR)  is  the  study  of  the  relationship  between  the 
compound’s molecular structure and its biological activity. The analysis of SAR allows scientists 
not only to pinpoint the chemical groups responsible for the target biological effect, but also to 
modify the compounds to achieve the greatest potency and least side effects.
The  basic  structure  of  Angelmarin  is  a  coumarin  (6,  Figure  4)  core.  Coumarins  are 
ubiquitous  in  a  number  of  natural  drugs  that  possess  an  extensive  range  of  physiological 
activities,  including  anticancer,  anti-viral,  antifungal,  anti-inflammatory,  antioxidant, 
anticoagulant,  antibacterial,  antitubercular,  and  analgesic  activities.  More  specifically, 
hydroxycoumarin derivatives have been found to show promising antitumor, anti-inflammatory, 
and anti-viral effects22. 
To investigate the relationship between the structures of coumarin derivatives and their 
preferential cytotoxic activity against pancreatic cancer cells, our lab started the first SAR studies 
of simple hydroxycoumarin-based compounds (7-16, Table 1) as potential anticancer agents. The 
compounds  were  tested  against  PANC-1  cells  under  nutrient-deprived  conditions.  While 
compounds 7-11 didn’t show any appreciable cytotoxic activity, compound 12 induced 100% cell 
death at a high concentration of 200µM. Analysis of the 5-carbon (compound 13), 10-carbon 











Figure 4. Structure of 
Coumarin.
longer carbon chain tails or higher hydrophobicity correlates to higher cytotoxic activity. At the 
same time, the geranylgeranyl hydroxycoumarin derivative, compound 15,  was discovered to 
exhibit the highest preferential cytotoxicity against PANC-1 at a concentration of 6.25µM22.
Compound Conc. for 100% death ND Compound
Conc. for 100% 
death ND
7 >200µM 8 >200µM
9 >200µM 10 >200µM
11 >200µM 12 200µM






















Table  1.  In  vitro  cytotoxicity  of  hydroxycoumarin  derivatives  (7-16)  against  PANC-1  under 
nutrient-deprived (ND) condition within 24h. Conc. obtained from Devi et al., 2011.22
SAR Study of Isoprenylated Coumarins
After  the  discovery  of  the  geranylgeranyl  coumarin  derivative  (9,  Table  1),  our  lab 
launched our second SAR studies on the relationship between the isoprenpyl positioning as well 
as the tail length and the cytotoxic activity against pancreatic cancer cells. A library consisting of 
three series of isoprenylated coumarin derivatives with systematic variations in the substitution 
position on the coumarin scaffold (at 3-, 6-, and 7-positions, Figure 4) and the tail length (5-, 10-, 
and 15-carbon) was created23-25.  These ether compounds were prepared via Williamson ether 
synthesis with an isopropyl bromide and an alkoxycoumarin (Scheme 1)23.
All  three  compound series  were  tested  in  vitro  against  PANC-1 cells  under  nutrient-
deprived (ND) and nutrient-rich (NR) conditions. The mean 50% lethal concentration (LC50) 
values after 24h exposure to the compounds are summarized in Table 2. All compounds were 
inactive under nutrient-rich conditions, and showed selective cytotoxicity only under nutrient-
deprived conditions. In addition, within each series, the same trend was observed: increase in tail 
length corresponds with decrease in LC50 values and increase in cytotoxic activity23. 
Among  all  isoprenylated  coumarin  derivatives  tested,  compound  21  displayed  the 
greatest cytotoxicity under nutrient-deprived conditions with an LC50 value as low as 4µM23. To 
better understand the preferential cytotoxicity and to investigate the potential cellular mechanism 
of our coumarin derivatives, we have picked compound 21  to be our lead compound for the 
future studies because of its highest potency.  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Series Compound LC50 (µM) ND
LC50 (µM) 
NR
1 17 >100 >100
18 37 >100
16 12 >100
2 19 >100 >100
20 12 >100
21 4 >100



















Table 2. In vitro cytotoxicity of isoprenylated coumarin derivatives (13-14, 16-22) against PANC-1 under 
nutrient-deprived (ND) and nutrient-rich (NR) conditions within 24h. LC50 values obtained from Jun et al., 
2014.23
4. Preferential Cytotoxicity of Compound 21
Against Other Pancreatic Cancer Cell Lines
The anti-proliferative activity of lead compound 21 was also investigated in vitro against 
two other pancreatic cancer cell lines, BxPC-3 and Capan-2 (Figure 5). Similar to PANC-1, both 
cell lines exhibited cytotoxicity to 21 preferentially under nutrient-deprived conditions with LC50 




































0 25 50 75 100
NRM NDM
Figure 5. Survival of BxPC-3 and Capan-2 cells under nutrient-deprived medium (blue) and nutrient-rich medium 
(red)  after  24  h  incubation  with  compound  21.  All  cell  viabilities  are  means  of  ±  SEM,  n  =  3.  Replicate 
experiments were performed and similar values were obtained. Concentrations of compound 21 investigated were 
6.25, 12.5, 25, 50 and 100 μM. Data obtained from Zhang et al., 2016.24




Table 3. LC50 values under nutrient-deprived medium (NDM) and nutrient-rich medium (NRM) of 21 
against three pancreatic cancer cell lines: PANC-1, BxPC-3, and Capan-2. Data obtained from Zhang et 
al., 2016.24
Medium Component Study of Compound 21
To  better  understand  the  selective  anti-proliferative  activity  of  compound  21,  that 
preferential cytotoxicity was observed only under nutrient-deprived medium (NDM) while no 
cytotoxicity under nutrient-rich medium (NRM = NDM + glucose + serum + amino acids), we 
initiated medium component study of compound 21  against  PANC-1 cells.  In this study, the 
effects of three essential medium components, glucose (Glu), serum (Ser), and amino acids (AA) 
were investigated. To better focus on the effect of serum, we also used dialyzed serum (Dia Ser). 
PANC-1 cells were treated with 21 under medium conditions of different combinations of these 
nutrient components, and the survival of cells was examined after 24h incubation by using WST-
8 reagent. Medium conditions that demonstrated >25% cell death in the presence of 21 were 
designated  “Active”  and  NDM-like  (Figure  6A),  and  medium  conditions  that  demonstrated 
<25% cell death were designated “Inactive” and NRM-like (Figure 6B).
In  this  study,  the  critical  role  of  glucose  on  the  preferential  cytotoxicity  of  21  was 
noticed.  To  highlight  the  link  between  observed  cytotoxicity  and  glucose  deprivation,  we 
reported  percent  PANC-1  cell  death  at  100µM  21  under  specific  medium  condition  with 
reference  to  the  glucose  concentration  in  the  medium (Figure  7).  At  high  concentration  of 
glucose  in  media,  low  cell  death  was  observed  after  24h  incubation  with  21,  and  at  low 














































Figure 6. Survival of PANC-1 cells under different cell  culture medium conditions after 24 h incubation with 
compound 21.  All cell viabilities are means ± SEM, n = 3. Replicate experiments were performed and similar 
values were obtained. Concentrations of compound 21 investigated were 6.25, 12.5, 25, 50 and100 μM. A. Media 
compositions  that  demonstrate  >25%  cell  death  in  the  presence  of  21  are  designated  “Active.”  B.  Media 
compositions that demonstrate <25% cell death in the presence of 21 are designated “Inactive.” Data obtained from 
Zhang et al., 2016.24
A.
B.
Our  finding  showed  with  the  presence  of  glucose,  compound  21  is  less  cytotoxic; 
however, with the absence of glucose, 21 becomes increasingly effective, implying 21 targets a 
salvage pathway when glycolysis is not an option for providing energy for cancer cell survival. 
Autophagy13,14,27, the regulated cytological degradation and recycling, has been found to provide 
a  mechanism to  sustain  pancreatic  cancer  cells  under  nutrient  starvation.  This  leads  to  our 
hypothesis that the mechanism of 21 is via an inhibition of autophagy.
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Figure 7. Percent PANC-1 cell death upon exposure for 24 h to 100 μM of compound 21  under different cell 
culture medium conditions. All experiments were performed in triplicate, and the results are shown as means ± 
SEM. The final concentration of glucose (μg/mL) in each medium, plotted on a log scale, is overlayed with the 
corresponding viability histogram. Figure obtained from Zhang et al., 2016.24
5. Introduction to Investigation
The research presented herein will be comprised of five studies with the ultimate goal to 
investigate the mechanism of compound 21. First, to prepare pure compound 21 for biological 
evaluation; second, to perform time dependent study to find out the anti-proliferative activity of 
21 in respect to time; third, to compare medium component study results for three pancreatic 
cancer  cell  line,  PANC-1,  BxPC-3,  and  Capan-2;  fourth,  to  use  commercially  available 
autophagy detection kit to learn the effect of 21 on the amount of autophagosomes; lastly, to 
detect  the  effects  of  21  and  autophagy  inhibitors  on  expression  of  LC3-I  and  LC3-II  with 
Western blotting.
1) Preparation of Compound 21
Compound 21 will be synthesized through 2 steps: deprotonation of 6-hydroxycoumarin 
23  with  sodium  hydride  in  DMF,  and  then  a  Williamson  ether  synthesis  between  6-
hydroxycoumarin anion and farnesyl bromide 24 (Scheme 2).
2) Time Dependent Study
The aim for  the  time dependent  study is  to  find out  the  anti-proliferative  activity  of 
compound 21 in respect to time. PANC-1 cells will be treated with and without 21 in nutrient-






HO 1. NaH, DMF
2.
2123 24
Scheme 2. Synthesis of farnesylated coumarin 21.
3) Medium Component Study on BxPC-3 and Comparison 
(a)  New Reference Validation
In the previous medium component study on PANC-1, cell survival of cancerous cells not 
treated with 21 was defined as the control or 100% cell survival for each medium condition, and 
cell survival of empty wells with just medium was defined as the blank or 0% cell survival. 
However, since we were comparing this blank with conditions where most cells died, the empty 
well  with  just  medium was  not  a  true  representation  of  100% cell  death.  Thus,  this  subtle 
difference between 100% cell death and 0% cell survival often resulted in negative cell viability 
values, and it was not reasonable to have more than 100% cell death. 
We propose a new reference blank, the cell survival of cancerous cells treated with 1% 
Triton X-100 (25, Figure 8) in NDM. Triton is a widely used nonionic detergent that can kill and 
lyse cells at a low concentration. Such toxicity is due to the disruptive action of Triton’s polar 
head on the cell’s lipid bilayer, and the insertion of Triton monomer into the membrane28. The 
exposure of cancerous cells to 1% Triton X-100 for 5 minutes could already induce 100% cell 
death. The survival of cancerous cells treated with Triton will serve as a better blank for the cell 
cytotoxicity assays.
(b)  Medium Component Study on BxPC-3
To investigate whether there is  a similar link between the preferential  cytotoxicity of 
farnesylated coumarin 21 and glucose deprivation for other pancreatic cancer cell lines, we will 
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Triton X-100 (25)
Figure  8.  Structure  of 
Triton X-100, n=9-10.
perform a medium component study on BxPC-3 cells, similarly to the one performed for PANC-
1. Compound 21 will be tested in vitro for its anti-proliferative activity against BxPC-3 under 
eleven different medium conditions.
(c)  Comparison Among Three Pancreatic Cancer Cell Lines
The media component studies for all three pancreatic cancer cell lines, PANC-1, BxPC-3, 
and Capan-2 (the data for Capan-2 were obtained by Yin Wang’16) will be compared to find 
whether there is a similar dependence on glucose for the preferential cytotoxicity of 21.  If a 
similar  link  between selective  cytotoxicity  and glucose  deprivation  is  observed for  all  three 
pancreatic cancer cell lines, this suggests 21 targets a pathway shared by most types of pancreatic 
cancer cells.
4) Cyto-ID® Kit Study of Autophagy in PANC-1
The objective of this study is to investigate whether inhibition of autophagy, the recycling 
of  nonessential  cellular  components  for  cancer  cell  survival  under  nutrient  deprivation,  is  a 
possible mechanism of compound 21 by using a commercially available Cyto-ID® Autophagy 
Detection kit from ENZO® Life Science Inc. The kit contains the Cyto-ID® Green Detection 
Reagent  that  could  stain  autophagosomes (Figure  9),  the  double-membrane vesicles  that  are 
formed in the process of autophagy, and emit fluorescence in the green region of the visible light 
spectrum. This cell analysis kit provides a rapid and specific approach for monitoring autophagic 
activity at the cellular level.
Starvation activates autophagy with an induction time of 1 to 4 hours, and NDM lacking 
all  nutrients  represents  the  condition  of  starvation.  Rapamycin  (26,  Figure  9),  a  lipophilic 
macrolide  antibiotic,  induces  autophagy  by  inhibiting  the  mammalian  target  of  Rapamycin 
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(mTOR), which is a kinase that inhibits autophagy through phosphorylation of proteins involved 
in  the  process  of  autophagy.  Rapamycin-induced  autophagy  results  in  the  accumulation  of 
autophagosomes. Chloroquine (27, Figure 9), an anti-inflammatory drug for malaria, suppresses 
autophagy by increasing lysosomal pH and inhibiting lysosomal activity. Chloroquine blocks the 
formation of autolysosome or degradation of autophagosomes, leading to the accumulation of 
autophagosomes as well. Both rapamycin 26 and chloroquine 27 are included as positive controls 
in this kit.
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Figure 9. Schematic depiction of autophagy. Autophagosome, a double-membrane vesicle, is formed by 
sequestering cytosolic material. The outer membrane of the autophagosome fuses with the lysosome, and 
the internal material is degraded in the autolysosome. Microtubule-associated protein light chain 3 (LC3) 
exists in two molecular forms. LC3-I, localized in the cytoplasm, can be converted into the LC3-II, which is 
associated with the autophagosome membrane. Starvation and rapamycin (Rapa, 26) function as autophagy 
inducers, chloroquine (CQ, 27) as autophagy inhibitor by blocking degradation of autophagosomes, and 
wortmannin (WM, 28) as autophagy inhibitor by blocking formation of autophagosomes. Picture edited 
from Hashimoto et al., 2014.14
Rapamycin (26) Chloroquine (27) Wortmannin (28)
Starvation
Rapa
In this experiment, we will use fluorescence microscopy to visually observe the stained 
autophagosomes by Cyto-ID® Green Detection Reagent in PANC-1 cells treated with different 
medium conditions, and fluorescence microplate assay to read the fluorescence or the amount of 
autophagosomes in PANC-1 cells.
5) Western Blotting Analysis of Autophagy in PANC-1
One main challenge of Cyto-ID® Autophagy Detection kit is it only measures the amount 
of autophagosomes. However, both the induction of autophagy, by reagent like rapamycin 26 that 
induces  formation  of  autophagosomes,  and  the  inhibition  of  autophagy,  by  reagent  like 
chloroquine 27  that  blocks degradation of autophagosomes to autolysosomes,  could result  in 
accumulation of autophagosomes. Therefore, we will focus on Western blotting to better look 
into the autophagic activity in the cell.
Microtubule-associated protein 1 light chain 3 (LC3) is the protein we will use to monitor 
autophagy in PANC-1 cells. LC3 have two molecular forms: LC3-I localized in the cytoplasm 
and LC3-II bound to the autophagosome membrane14 (Figure 9). LC3-I converts into LC3-II by 
conjugating  with  phosphatidylethanolamine  (PE),  and  although  LC3-II  has  larger  molecular 
weight than LC3-I due to the addition of PE, LC3-II still migrates faster on the gel due to its 
extreme hydrophobicity29. LC3-I is usually detected on a gel at a molecular mass around 16kD, 
and  LC3-II  at  around  14kD.  The  amount  of  LC3-II  is  closely  related  to  the  amount  of 
autophagosomes  and  serves  as  a  good  indicator  for  autophagosomes  formation30.  The 
concentrations  of  LC3-I  and  LC3-II  will  be  normalized  against  glyceraldehyde-3-phosphate 
dehydrogenase (GAPDH), a housekeeping protein detected around 37kD.
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Sequestosome 1 (SQSTM1/p62) is another protein we will use to detect the autophagic 
flux29,31.  p62  binds  directly  to  LC3  and  serves  as  a  selective  substrate  of  autophagy.  The 
accumulation of p62 could suggest an inhibition of autophagy32; however, mechanisms other 
than   autophagy could also alter the expression of p6229. So the concentration of p62 will be 
used as an additional evidence, but not as an absolute indicator.
In this experiment, the effect of compound 21 on autophagy will be compared with that 
of  two  autophagy  inhibitors,  chloroquine  (27,  Figure  9)  and  wortmannin  (28,  Figure  10). 
Chloroquine  blocks  the  degradation  of  autophagosomes,  and  wortmannin,  the 
phosphatidylinositol-3-kinase (PI3K) inhibitor, blocks the formation of autophagosomes. 
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RESULTS AND DISCUSSION
1)   Preparation of Compound 21
The farnesylated  coumarin  21  was  synthesized  through  a  Williamson ether  synthesis 
between  farnesyl  bromide  24  and  6-hydroxycoumarin  sodium  alkoxide  pre-generated  from 
deprotonation of 6-hydroxycoumarin 23 with sodium hydride in DMF (Scheme 2). The desired 
product  was  purified  through  Preparative  Thin  Layer  Chromatography  (Prep  TLC),  and  its 
structure  confirmed  by  High  Resolution  Mass  Spectrometry,  Hydrogen  Nuclear  Magnetic 
Resonance (1H-NMR), and Carbon Nuclear Magnetic Resonance (13C-NMR). 
Several  small  uncharacterizable  peaks  around  0.7-1.6  ppm  in  1H-NMR  spectrum  of 
isolated  product  21  in  chloroform-d  were  resolved  with  the  500MHz NMR,  suggesting  the 
presence of some possible impurities. However, after two additional purification attempts, the 
tiny peaks remained (Figure 10A). The 1H-NMR spectrum of plain silica gel washed with 2% 
methanol in dichloromethane, the same eluting solution for purification of compound 21, also 
contained similar small peaks between 0.7-1.7 ppm (Figure 10B). This suggested the small peaks 
in the 1H-NMR spectrum of 21 probably resulted from organic components in TLC silica gel that 
were dissolved by the eluting solution during the process of purification.  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Figure 10. 1H-NMR spectra of compound 21 purified through Prep TLC (A) and plain silica gel washed with 2% 
methanol in dichloromethane (B) in chloroform-d.
A. 1H-NMR of 
Compound 21







2)   Time Dependent Study
The time dependent study aimed to find out the anti-proliferative activity of compound 21 
in respect to time. PANC-1 cells were treated with and without 21 in nutrient-deprived medium 
(NDM) and nutrient-rich  medium (NRM) for  8,  16,  24,  48,  and 72 hours  (Figure  11).  Our 
previous studies have found that 21 exhibits selective cytotoxicity against PANC-1 cells under 
nutrient-deprived conditions with an LC50 value of 9µM for 24-hour incubation (Table 3). In this 
study, exposure of PANC-1 cells to 10µM 21  for 24 hours induced 50% cell death in NDM 
(Figure 11A). Furthermore, the presence of 21 began to show anti-proliferative activities after 8 
hours of exposure in NDM, and PANC-1 cells reached 100% cell death in NDM, both with and 
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Figure 11. Survival of PANC-1 cells under nutrient-deprived medium (blue) and nutrient-rich medium (red), and 
PANC-1 cells treated with 10µM compound 21 under nutrient-deprived medium (green) and nutrient-rich medium 
(orange) after 8-, 16-, 24-, 48-, and 72-hour incubations. The survival of PANC-1 not treated with compound 21 
under nutrient-rich conditions after 8h incubation was defined as 100% survival reference. Graph B  had media 
changed at 24h and 48h incubation. All cell survivals are means of ±SEM, n = 3. Replicate experiments were 






At the same time, the presence of 21 didn’t exhibit any anti-proliferative effect against 
PANC-1 in NRM until 72 hours of incubation (Figure 11A). The survival of PANC-1 cells under 
nutrient-rich  conditions  for  8-hour  incubation  was  defined  as  100% survival  reference.  The 
increase of cell survival represented continued cell growth in NRM, until 72 hours of incubation, 
when there was a sudden drop in of cell survival, and more pronounced drop with the presence of 
21. It was hypothesized that the drop could have been caused by the depletion of nutrients in 
NRM  after  48  hours  of  incubation,  so  that  the  NRM  became  NDM  like,  resulting  in  cell 
inhibition in the depleted medium and more severe cell death with the exposure to 21.
To  test  this  hypothesis,  a  similar  experiment  was  conducted  where  the  media  were 
changed after  24-hour  and 48-hour  incubations (Figure 11B).  Therefore,  PANC-1 cells  were 
provided with sufficient nutrients in NRM for the duration of the experiment. As expected, there 
was no more survival drop after 72 hours of incubation, but a steady increase of cell growth, and 
no anti-proliferative activity of 21 was observed under nutrient-rich conditions. With even longer 
incubation, PANC-1 cell growth may reach an equilibrium because of the carrying capacity.
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3)   Medium Component Study on BxPC-3 and Comparison
(a) New Reference Validation 
To better represent 100% cell death, we decided to use the cell survival of pancreatic 
cancer cells treated with 1% Triton X-100 (25, Figure 8) in NDM as reference, instead of the 
previous cell survival of empty well with just medium as blank. To validate the credibility of this 
new reference, we repeated the same media component study on PANC-1 with this new blank 
(Figure 8). In Figure 12, the dashed lines represent the cell viabilities with the old blank, and the 
solid lines represent the cell viabilities with the new blank. The new blank helped to eliminate 
the  problem of  negative  cell  survival.  Because  of  the  biological  variability,  there  are  some 
fluctuations between the data generated using old blank and those with the new blank, but the 
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Figure  12.  Comparison  of  the  viabilities  of  PANC-1  cells  under  different  medium  conditions  after  24-hour 
incubation with compound 21 with old blank (just media, dashed line) and with new blank (cells treated with 1% 
Triton X-100, solid line). All cell survivals are means ± SEM, n = 3. Replicate experiments were performed and 
similar values were obtained. Concentrations of compound 21 investigated were 6.25, 12.5, 25, 50 and 100 μM.
(b) Medium Component Study on BxPC-3
To investigate whether there is  a similar link between the preferential  cytotoxicity of 
compound 21  and glucose deprivation for other pancreatic cancer cell lines, we performed a 
medium  component  study  on  BxPC-3  cells,  similarly  to  the  one  performed  for  PANC-1. 
Compound 21 was tested in vitro for its anti-proliferative activity against BxPC-3 under different 
medium conditions  (Figure  13).  Nutrient-rich  medium (NRM)  containing  all  three  essential 
medium components: amino acid (AA), glucose (Glu), and serum (Ser), and nutrient-deprived 
medium (NDM) lacking all three nutrients were selected as references. We used dialyzed serum 
(Dia Ser) with glucose concentration of less than 5µg/ml, to minimize the effect of glucose in 
serum with glucose concentration of 96µg/ml. A total of 11 medium conditions were tested, and 
the survival of BxPC-3 cells was examined after 24 hours of incubation with 21 by the WST-8 
cell counting reagent. 
Cell survival of BxPC-3 cells not treated with 21 was defined as 100% cell survival for 
each medium condition, and cell survival of BxPC-3 treated with 1% Triton X-100 defined as 0% 
cell  survival.  Media  conditions  that  demonstrate  >35% cell  death  in  the  presence of  21  are 
considered “Active” or NDM-like (Figure 13A), and media conditions that demonstrate <35% 
cell  death  in  the  presence  of  21  are  considered  “Inactive”  or  NRM-like  (Figure  13B).  The 
medium combination of NDM and dialyzed serum and/or amino acid still exhibited a similar 
effect on the cytotoxicity of 21 as NDM (Figure 13A), indicating the relatively unimportant role 
of Dia Ser and AA in the preferential cytotoxicity of 21.  On the other hand, the presence of 
glucose or low levels of glucose in serum rendered the medium inactive and behave like NRM 
(Figure  13B).  The  result  showed  a  similar  link  between  observed  cytotoxicity  and  glucose 
deprivation in media.  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Figure 13. Survival of BxPC-3 cells under different cell culture medium conditions after 24-hour incubation with 
compound 21. All cell survivals are means ± SEM, n = 3. Replicate experiments were performed and similar values 
were  obtained.  Concentrations  of  compound 21  investigated  were  6.25,  12.5,  25,  50  and  100  μM. A.  Media 
compositions  that  demonstrate  >35%  cell  death  in  the  presence  of  21  are  designated  “Active.”  B.  Media 
compositions that demonstrate <35% cell death in the presence of 21 are designated “Inactive.”
A.
B.
(c) Comparison Among Three Pancreatic Cancer Cell Lines
Figure 14 compiles the results of the media component studies for all three pancreatic 
cancer cell lines, PANC-1, BxPC-3, and Capan-2 (the data for Capan-2 were obtained by Yin 
Wang’16). The cell death (Figure 14A) and cell survival (Figure 14B) of cancerous cells treated 
with 100 μM compound 21 for 24 hours in various cell culture media conditions are reported, as 
well as the final glucose concentration on a log scale in each condition.
A similar  overall  trend  is  observed  for  all  three  pancreatic  cancer  cell  lines:  higher 
glucose concentration in medium results in lower cell death or higher cell survival when treated 
with  21,  in  other  words,  less  anti-proliferative  activity  of  21.  In  general,  the  similar  trend 
indicates the same link between the selective cytotoxicity of 21 and glucose deprivation for all 
these three cell  lines,  suggesting 21  targets  the pathway shared by most  types of  pancreatic 
cancer cell lines. 
It is also important to point out that Capan-2, compared with PANC-1 and BxPC-3, is 
much more sensitive to any glucose concentration in medium. The high sensitivity is highlighted 
by the medium conditions of NDM+Dia Ser and NDM+Dia Ser+AA, in which the final glucose 
concentration is only 5µg/mL, behaving as NDM-like for PANC-1 and BxPC-3, but NRM-like 
for  Capan-2.  This  difference in  sensitivity  might  result  from the intrinsic  differences  in  cell 
















































Media Component Effect of Compound 21 - Cell Survival













































Media Component Effect of Compound 21 - Cell Death
PANC-1 death at 100µM BxPC-3 death at 100µM Capan-2 death at 100µM Log(Glucose Conc.)
Figure 14. Percent PANC-1 (green), BxPC-3 (blue), and Capan-2 (orange, data generated by Yin Wang’16) cell 
death (A) and cell  survival (B) upon exposure for 24 hours to 100 μM of compound 21  in cell  culture media 
conditions of various nutrient components (glucose, amino acid, serum, and dialyzed serum). All results are means ± 
SEM, n=3. The final concentration of glucose (μg/mL) in each medium condition, plotted on a log scale (pink), is 
overlayed with the corresponding viability histogram.
A.
B.
4)   Cyto-ID® Kit Study of Autophagy in PANC-1
The objective of this study is to investigate whether inhibition of autophagy, the recycling 
of nonessential cellular components, is a possible mechanism of compound 21 by looking into 
the amount of autophagosomes with a commercially available Cyto-ID® Autophagy Detection kit 
from ENZO® Life Science Inc. Rapamycin (26, Figure 9), autophagy inducers, and chloroquine 
(27,  Figure  9),  autophagy  inhibitor  by  blocking  formation  of  autolysosome,  will  lead  to 
accumulation of autophagosomes and are used as positive controls in this experiment.
(a) Fluorescence Microscopy
The first series of experiments with this kit was using fluorescence microscopy to visually 
observe the stained autophagosomes.  To determine the optimal condition of positive control, 
PANC-1 cells were treated with various combinations of different concentrations of chloroquine 
27 (10, 50, and 100µM) and rapamycin 26 (0.5, 1, and 2µM) under both NRM and NDM for 18 
hours, incubated with Cyto-ID® Green Detection Reagent for 30 minutes while protected from 
light,  and  analyzed  with  fluorescence  microscopy by  using  FITC filter  set  (Figure  15).  The 
combination of 50µM chloroquine and 1µM rapamycin gave the most intense signal, and was 
defined as the positive control.  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Figure 15. Fluorescence image of PANC-1 cells 
stained with Cyto-ID®. PANC-1 cells were plated 
in a 8-well chamber plate overnight, treated with 
different  combinations  of  chloroquine  (10,  50, 
and  100µM)  and  rapamycin  (0.5,  1,  and  2µM) 
concentrations under both NRM and NDM for 18 
hours,  and  incubated  with  Cyto-ID®  Green 
Detection Reagent for 30 minutes while protected 
from  light.  The  pictures  were  taken  with 
fluorescence microscopy with FITC filter set. The 
green dots are the autophagosomes.
The next goal was to determine the effect of compound 21 on the autophagic activity of 
cells. PANC-1 cells were treated without 21, with 10µM 21, with positive control, and with the 
combination  of  positive  control  and  21  under  both  NRM  and  NDM  (Figure  16).  In  this 
experiment, there was a slight increase in fluorescence from cells in NDM compared to those in 
NRM, indicating the effect of starvation on inducing autophagy. The cells also demonstrated 
intense fluorescence when treated with positive control, but barely any fluorescence when treated 
with  just  media  or  media  and  21.  Therefore,  no  valid  conclusion  could  be  reached  about 
differences in fluorescence of PANC-1 untreated and treated with 21. 
The rapid fluorescence decay of Cyto-ID® Green Detection Reagent within the range of 
minutes was a significant challenge working with this kit. Even with the best efforts to prevent 
any light exposure, there was always a delay in time from when light hit the cell and when 
picture was taken manually. In addition, when light hit one well, the cells in other wells would 
inevitably  receive  some  scattered  light,  decreasing  the  fluorescence  signal.  As  result,  the 
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Figure 16. Fluorescence image of PANC-1 cells 
stained with Cyto-ID®. PANC-1 cells were plated 
in a 8-well chamber plate overnight, treated with 
plain media, with 10µM 21, with positive control 
(50µM  chloroquine  and  1µM  rapamycin),  and 
with the combination of 21  and positive control 
under  both  NRM and  NDM for  20  hours,  and 
incubated  with  Cyto-ID®  Green  Detection 
Reagent  for  30  minutes  while  protected  from 
light. The pictures were taken with fluorescence 
microscopy with FITC filter set. The green dots 
are the autophagosomes.
fluorescence  images  could  not  serve  as  conclusive  evidence  for  the  effect  of  21  on 
autophagosomes. Consequently, we decided to move to a fluorescence microplate assay, which 
could  not  only  minimize  the  effect  of  fluorescence  decay  when  reading  with  an  automated 
microplate reader, but also provide with quantitative data.
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(b) Fluorescence Microplate
In the first attempt with the microplate assay, PANC-1 cells were treated under the same 
eight conditions as the previous fluorescence microscopy experiment for 24 hours, and the blank 
employed was assay buffer provided in the kit (Figure 17). The fluorescence readings for cells 
treated with positive control were high, and even higher when 21 was present for both NRM and 
NDM, indicating possible effect of 21 on autophagic activity. However, the differences between 
cells untreated and treated with 21 for both NRM and NDM were not significant.
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Figure 17. Fluorescence reading of PANC-1 cells stained with Cyto-ID®. PANC-1 cells were plated in a 96-well 
clear bottom black microplate overnight, treated with plain media, with 10µM 21, with positive control (50µM 
chloroquine and 1µM rapamycin), and with the combination of 21 and positive control under both NRM and NDM 
for 24 hours, and incubated with Cyto-ID® Green Detection Reagent for 30 minutes while protected from light. The 
plate was top read with a fluorescence microplate reader with excitation at 480nm and emission at 530nm. Three 
replicate wells for each media condition, nine readings for each well for each read, and three reads were employed. 
Readings below the reading of background, which was assay buffer, were removed. The reported fluorescence is the 
mean of readings subtracted by the background reading, and the error bar represents SEM.
A few  problems  arose  when  analyzing  the  fluorescence  data.  The  first  was  a  high 
background reading. The reported fluorescence was calculated by subtracting the background 
reading from the mean of readings for the cells. The background was assay buffer without any 
cells, which should not have any fluorescence, but gave an average reading of 4.4, while the 
readings for the cells treated with Cyto-ID® reagent were around 4.7-5.3, and subtracting the 
background from the actual reading resulted in small reported fluorescence output of around 0.3-
0.9. Another problem was that many readings were below the background reading, indicating 
these readings didn’t hit the cells. After consulting with the technical support from ENZO®, we 
improved the experimental design. To solve the problem of high background reading, the blank 
would  be  changed  to  cells  treated  with  the  same  medium  condition  but  without  Cyto-ID® 
reagent, since the fluorescence readings for cells and for just media were not comparable. This 
new blank could also eliminate the interference of the possible fluorescence of compound 21. To 
reduce readings below background reading, the incubation time was shortened, so that fewer 
cells would die and detach during incubation, especially under nutrient-deprived conditions. In 
addition, 24 hours was too long to observe the effect of starvation. Lastly, the microplate would 
be read from the bottom instead of from the top, so that the cells could be brought as close as 
possible to the detector and the noise from overlying media could be avoided. 
With these modifications to the experimental design in place, two more attempts of 4 and 
8 hours incubation (Figure 18A) and 2 hours incubation (Figure 18B) with PANC-1 cells under 
the same eight media conditions were performed.  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Figure 18. Fluorescence reading of PANC-1 cells stained with Cyto-ID®. PANC-1 cells were plated in a 96-well 
clear bottom black microplate overnight, treated with plain media, with 10µM 21, with positive control (50µM 
chloroquine and 1µM rapamycin), and with the combination of positive control and 21 under both NRM and NDM 
for 4 and 8 hours (A) and 2 hours (B), and incubated with Cyto-ID® Green Detection Reagent for 30 minutes while 
protected from light. The plate was bottom read with a fluorescence microplate reader with excitation at 480nm and 
emission at 530nm. Three replicate wells for each media condition, nine readings for each well for each read, and 
two reads were employed. Readings below the reading of background, which was cells treated with the same 
conditions but without Cyto-ID®, were removed. The reported fluorescence is the mean of readings subtracted by 
the background reading, and the error bar represents SEM.
Starvation has an induction time of 1-4 hours. With the 2-hour incubation (Figure 18B), 
there was a slight increase of fluorescence in NDM compared to that in NRM, which might 
suggest the effect of starvation, yet the difference was very small.  In NRM, the presence of 
compound  21  resulted  in  an  increase  of  fluorescence,  representing  higher  level  of 
autophagosomes. The increase was evident when comparing the readings for NRM 2h/4h and 
those  for  NRM+21  2h/4h,  and  the  reading  for  NRM+positive  control  and  that  for 
NRM+21+positive control. One possible explanation for this increase of autophagosomes by 21 
is under nutrient-rich conditions, glycolysis is available to provide energy for PANC-1, and the 
presence  of  21  triggers  PANC-1  cells  to  initiate  autophagy  as  a  cytoprotective  mechanism, 
resulting in the accumulation of autophagosomes, so that cells could still survive with presence 
of 21 under NRM. 
In NDM, on the other hand, the presence of 21 did not have much effect on fluorescence. 
A possible hypothesis could be that under nutrient-deprived conditions, glycolysis is already not 
available  to  provide  energy,  the  presence  of  21  triggers  cells  to  initiate  autophagy  as 
cytoprotective mechanism and as energy source, but autophagy is inhibited by 21 in NDM, so 
the autophagosomes remain unaffected at baseline level and cells die with presence of 21 under 
NDM.  Based  on  the  data  obtained,  there  was  no  conclusive  evidence  to  support  either 
hypothesis. Nevertheless, 21 did seem to have some effect on the level of autophagosomes in 
NRM. A repeated assay is needed to validate the finding, but unfortunately, the Cyto-ID® reagent 
was used up and the kit was too expansive to experiment with.
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5)   Western Blotting Analysis of Autophagy in PANC-1
(a) Effects of 21 and Autophagy Inhibitors on Conversion of LC3-I to II 
In this experiment, cell lysates were prepared by treating PANC-1 cells with plain media, 
10µM 21,  25µM chloroquine (27,  Figure 9),  or 1µM wortmannin (28,  Figure 9) under both 
nutrient-deprived medium (NDM) and nutrient-rich medium (NRM) for 24 hours. Due to the 
short half-life of wortmannin14, PANC-1 was incubated with wortmannin for 4 hours, and then in 
either  NRM  or  NDM  for  the  other  20  hours.  The  protein  concentrations  of  cell  lysate 
supernatants  were measured with NanoDrop.  Supernatants  of  equal  amounts of  protein were 
mixed with Laemmli sample buffer, boiled for 5 minutes, and ran on a 4-20% Mini-PROTEAN® 
TGX gel. The proteins were then transferred from the gel to a polyvinylidene difluoride (PVDF) 
membrane, which was blocked with blocking buffer, then treated with polyclonal LC3, GAPDH, 
and  p62  antibodies  separately,  and  then  secondary  antibody.  The  ladder  used  was  WesterC 
Standards detected by Strep Tactin-HRP, and the band densities were measured with Image Lab 
(Figure 19).
Chloroquine is an autophagy inhibitor by blocking the degradation of autophagosomes, 
and LC3-II is the form of LC3 that is attached to the membrane of autophagosomes. Western 
blotting showed that treating PANC-1 cells with chloroquine under both NRM and NDM results 
in  an  accumulation of  LC3-II  (Figure  19).  On the  other  hand,  wortmannin  is  an  autophagy 
inhibitor by blocking the formation of autophagosomes, and as shown by the Western blotting, 
treating PANC-1 cells with wortmannin under both NDM and NRM decreases the level of  LC3-
II.   PANC-1 cells  under  nutrient-deprived conditions  in  general  also  showed an  increase  of 
conversion  of  LC3-I  to  LC3-II  than  those  under  nutrient-rich  conditions,  suggesting  the 

























Figure 19.  Effects  of  21  and autophagy inhibitors  on expressions of  LC3-I,  LC3-II,  and p62 in 
PANC-1. Western blot analysis was performed on cell lysates after treating PANC-1 cells with plain 
media, 10µM 21, 25µM chloroquine (CQ), or 1µM wortmannin (WM) under both nutrient-deprived 
medium  (NDM)  and  nutrient-rich  medium  (NRM)  for  24  hours.  Cell  lysate  supernatants  with 
Laemmli sample buffer were loaded and ran on a 4-20% Mini-PROTEAN® TGX gel. Proteins were 
transferred from gel to PVDF membrane, which was blocked with blocking buffer, then treated with 
polyclonal LC3, GAPDH, and p62 antibodies separately, and secondary antibody. The ladder on the 
rightmost  lane  was  WesterC  Standards  detected  by  Strep  Tactin-HRP.  The  band  densities  were 












GAPDH 20222.3 24122.3 26042.4 27575.1 24258.2 28565.2 30864.4 33770.4
LC3-I 15156.2 17303.5 21028.7 18593.0 11673.6 10262.8 17450.8 18893.2
LC3-I ratio to 
GAPDH 0.75 0.72 0.81 0.67 0.48 0.36 0.57 0.56
LC3-II 11965.3 15915.9 26158.1 15274.8 18279.8 19258.0 30927.8 17899.8
LC3-II ratio to 
GAPDH 0.59 0.66 1.00 0.55 0.75 0.67 1.00 0.53
LC3-II/LC3-I 0.79 0.92 1.24 0.82 1.57 1.88 1.77 0.95
p62 13096.3 12319.8 15463.4 14711.0 15215.7 17518.1 14559.7 16760.3
p62 ratio to 
GAPDH 0.65 0.51 0.59 0.53 0.63 0.61 0.47 0.50
 Expressions of LC3-I and LC3-II in PANC-1 did not have significant changes with the 
24-hour treatment of compound 21 under NRM (Figure 19), agreeing with what we previously 
knew about compound 21 that it shows no cytotoxicity under NRM. On the other hand, treating 
PANC-1 cells with 21 under NDM for 24 hours increased the conversion of LC3-I to LC3-II (the 
LC3-II to LC3-I ratio is 1.57 under NDM and 1.88 under NDM+21), possibly suggesting an 
inhibition of  autophagy in the same way as chloroquine inhibiting autophagy.  This  potential 
inhibition  of  autophagy  under  nutrient-deprived  conditions  agrees  with  the  preferential 
cytotoxicity of 21 only under glucose deprivation.
p62,  or  SQSTM1,  is  another  protein  we  monitored.  The  accumulation  of  p62  could 
suggest an autophagy inhibition32. However, treating PANC-1 cells with autophagy inhibitors, 
chloroquine and wortmannin, under both NRM and NDM resulted in a decrease in the level of 
p62, suggesting the levels of p62 were influenced by pathways other than autophagy in the cells. 
Therefore, the expression of p62 was not used to detect the effect of 21 on the autophagic flux in 
PANC-1 cells.
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(b) Conversion of LC3-I to II Dependent on Time of Incubation
We have noticed that the structure of 21 shares some similarity with that of chloroquine, 
the autophagy inhibitor (27, Figure 9). To better investigate the effect of 21 on the autophagic 
activity in PANC-1 and to compare that with the effect of chloroquine, we closely looked into the 
survival of PANC-1 cells and expressions of LC3-I and LC3-II as dependent on time of treatment 
with 21 or chloroquine. In this study, PANC-1 cells were treated with plain medium, 10µM 21, 
or 25µM chloroquine under both nutrient-deprived medium (NRM) and nutrient-rich medium 
(NDM) for  3,  7,  12,  and 24 hours.  Cytotoxicity  assays  were performed to  find out  the  cell 
survival  (Figure  20A),  and Western  blotting  analysis  were  performed on cell  lysates  treated 
under the same conditions to detect the expressions of LC3-I and LC3-II (Figure 20B).
 Under  nutrient-rich  conditions,  both  21  and  chloroquine  didn’t  exhibit  any  cell 
cytotoxicity against PANC-1 (Figure 20A). In addition, the levels of LC3 proteins didn’t change 
significantly with treatment of 21 in NRM over different times of incubation; however, treating 
PANC-1 cells with chloroquine in NRM led to an accumulation of LC3-II with longer time of 
incubation, suggesting autophagy is inhibited by chloroquine even under NRM. 
Under  nutrient-deprived conditions,  anti-proliferative  activities  of  21  and chloroquine 
were not observed for the first 7 hours of incubation, probably because PANC-1 cells still had 
enough leftover nutrients when media were changed to NDM, so that they didn’t have to trigger 
alternate metabolic pathways for survival for the initial few hours of incubation. Both treatments 
of  21  and  chloroquine  under  NDM  exhibited  anti-proliferative  activities  after  24  hours  of 
incubation, and led to accumulations of LC3-II over time, suggesting 21 behaves as chloroquine 
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Figure 20.  A.  Survival  of  PANC-1 cells  treated with plain medium, 10µM 21,  or  25µM chloroquine (CQ) under 
nutrient-deprived medium (NDM) and nutrient-rich medium (NRM) for 3, 7, 12, and 24 hours. The survival of PANC-1 
after  0  hour  incubation  was  defined  as  100% survival.  All  cell  survivals  are  means  of  ±SEM,  n  =  3.  Replicate 
experiments were performed and similar values were obtained. B. Western blot analysis was performed on cell lysates 
after treating PANC-1 cells with plain media, 10µM 21, or 25µM chloroquine under both NDM and NRM for 3, 7, 12, 
and 24 hours. Cell lysate supernatants with Laemmli sample buffer were loaded and ran on 4-20% Mini-PROTEAN® 
TGX gels. Proteins were transferred from gels to PVDF membranes, which were blocked with blocking buffer, treated 




The link between preferential cytotoxicity of compound 21 against PANC-1 and glucose 
deprivation suggested 21  targets  a pathway when glycolysis  is  not  an option for  cancer cell 
survival. In this research, the anti-proliferative mechanism of 21  was investigated. The small 
peaks in 1H-NMR spectrum of 21 had been identified to be the organic components in TLC silica 
gel that were dissolved in the process of purification. In the time dependent study, 21 exhibited 
anti-proliferative  activities  from  8  hours  to  48  hours  of  exposure  in  NDM,  suggesting  its 
mechanism of action has a relatively short induction time. In the medium component study, a 
similar link between selective cytotoxicity and glucose deprivation was observed for all three 
pancreatic cancer cell lines, PANC-1, BxPC-3, and Capan-2, indicating 21  targets a pathway 
shared by most types of pancreatic cancer cells.
In the Cyto-ID® Autophagy Detection kit study, autophagosomes were visually observed 
with  a  commercially  available  fluorescence stain.  Although 21  did  not  have much effect  on 
fluorescence or the amount of autophagosomes under NDM, an increase of fluorescence was 
observed by the presence of 21 under NRM, suggesting the possible involvement of 21 in the 
process of autophagy. In the Western blotting analysis of autophagy, 21  was found to have a 
similar effect as chloroquine, an autophagy inhibitor, on increasing the conversion of LC3-I to 
LC3-II  in  PANC-1,  resulting  in  an  accumulation  of  LC3-II.  Furthermore,  while  21  and 
chloroquine exhibited anti-proliferative activity only under NDM, 21  increased conversion to 
LC3-II over time only under NDM, but chloroquine increased conversion to LC3-II under both 
NRM  and  NDM.  This  finding  suggests  while  chloroquine  inhibits  autophagy  under  all 
conditions,  21  inhibits  autophagy  only  under  NDM.  Understanding  its  anti-proliferative 
mechanism is one step toward the potential use of 21 as novel therapy against pancreatic cancer.  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METHODS AND MATERIALS
Preparation of Compound 21
Synthesis of 6-(((2E,6E)-3,7,11-trimethyldodeca-2,6,10-trien-1-yl)oxy)-2H-chromen-2-one
 Compound 21  was synthesized as described by Scheme 226. All reagents and solvents 
were purchased commercially from Sigma-Aldrich®. To an oven-dried 100 mL round bottom 
flask prepared with  a  magnetic  stirring bar,  a  rubber  septum cover,  and a  nitrogen inlet,  6-
hydroxycoumarin (1.14 g, 7.0 mmol) and 40 mL of anhydrous N,N-dimethylformamide (DMF) 
were added. The solution was cooled to 0 ºC in a salt-ice bath and sodium hydride (280 mg of 
60% mineral oil suspension, 7.0 mmol) was added to the flask. The solution was then stirred at 0 
ºC for 30 minutes. Farnesyl bromide (4.5 mL, 16.6 mmol) dissolved in 10 mL of anhydrous 
DMF was cooled to 0ºC and added dropwise to the reaction flask through the rubber septum 
using a syringe. The reaction mixture was left stirring under nitrogen with warming to room 
temperature overnight and concentrated in vacuum. 
Purification of Compound 21
The  desired  product  was  purified  via  Preparative  Thin  Layer  Chromatography  (7:3 
hexane:ethyl acetate). The eluting solution was 2% methanol in dichloromethane. 
Characterizations of Compound 21
The structure of 21  was confirmed by High Resolution Mass Spectrometry, Hydrogen 
Nuclear Magnetic Resonance (1H-NMR), and Carbon Nuclear Magnetic Resonance (13C-NMR). 
HRMS was performed on a 70-VSE mass spectrometer at the University of Illinois at Urbana-
Champaign Mass Spectrometry Facility. 21 was diluted in chloroform-d, and 1H- and 13C-NMR 
spectra were recorded on a Bruker AscendTM 500 spectrometer at 500 MHz (1H-NMR) or 125 
MHz  (13C-NMR).  Chemical  shifts  (δ)  were  reported  in  parts  per  million  (ppm)  relative  to 
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tetramethylsilane (TMS), and coupling constants were reported in Hz. 1H-NMR δ  1.60 -1.76 
(12H), 1.96-2.12 (8H), 4.57 (d, 2H, J=6 Hz), 5.10 (m, 2H), 5.48 (t, 1H), 6.43 (d, 1H, J=9 Hz), 
6.92-7.66  (4H);  13C-NMR δ  16.04,  16.74,  17.70,  25.70,  26.17,  26.71,  29.70,  39.53,  39.69, 
111.08, 117.02, 117.83, 118.93, 119.15, 129.13, 123.53, 124.27, 131.38, 135.57, 141.94, 143.25, 
148.42, 155.35, 161.04. HRMS (CI) Calcd. for C24H31O3: 367.22733; found: 367.22801.
Tumor Cell Culture and Media Preparations
Cell Lines
  Human pancreatic cancer cell lines, PANC-1, BxPC-3, and Capan-2 were obtained from 
American Type Culture Collection (ATCC). 
Tumor Cell Culture Procedures
To a cell-containing T-75/T-25 culture flask, a 2-5 mL aliquot of filtered trypsin-EDTA 
was added to detach the cells  after  the aspiration of  DMEM and a PBS wash.  The trypsin-
containing flask was placed in the incubator (37°C and 5% CO2) for 3 minutes. Detached cells 
were  transferred  to  a  15  mL centrifuge  tube  and  pelleted  for  3  minutes  at  1000  rpm.  The 
supernatant of the resulting content was aspirated. The cell pellet was re-suspended thoroughly in 
the complete DMEM and transferred to a new T-75/T-25 flask with additional DMEM to reach a 
final volume of 25/5 mL, and store in the incubator (Sheldon Manufacturing Inc.)
Preparation of Dulbecco Modified Eagle’s Medium (DMEM)
Pancreatic cancer cells were cultured in Dulbecco Modified Eagle’s Medium (DMEM). 
To prepare DMEM, one bottle of DMEM powder (Sigma-Aldrich) was dissolved in 800 mL of 
HPLC grade water. Sodium bicarbonate solution (49.1 mL) and antibiotic-antifungal solution (10 
mL, 100x) were added to the mixture. The volume was brought to 900 mL and the solution was 
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adjusted to a pH between 7-7.4. Heat-inactivated fetal bovine serum (FBS, 100 mL) was added 
to the neutralized solution and filtered via a 0.2-μm Corning filter.  The medium was stored at 4 
°C. Cells were passaged once to twice a week by trypsinization.
Preparation  of  Nutrient-Deprived  Medium  (NDM),  Nutrient-Rich  Medium  (NRM)  and 
Special Media Conditions
For all medium conditions, the following electrolytes and vitamin solution were added in 
concentrations as follows: CaCl2(2H2O), 265 mg/L; Fe(NO3)(9H2O), 0.1 mg/L; KCl, 400 mg/L; 
MgSO4(7H2O), 200 mg/L; NaCl, 6400 mg/L; NaHCO3, 700 mg/L; NaH2PO4, 125 mg/L; phenol 
red,  15  mg/L;  HEPES  buffer  (25mM,  pH  7.4);  and  MEM  vitamin  solution  (1x/L)  (Life 
Technologies, Inc., Rockville, MD), which completed the preparation of the NDM. For NRM, 
additional  nutrients  were  supplement  at  concentrations  as  follows:  D-glucose,  1000mg/L;  L-
glutamine, 2 mM; MEM amino acids solution and MEM nonessential amino acids solution (Life 
Technologies,  Inc.),  20 mL and 10 mL respectively for 1 L medium; FBS, 100 mL for 1 L 
medium.  For  all  special  media  combinations,  corresponding  combinations  of  nutrients  were 
added at concentrations identical to those in NRM. For media with dialyzed serum, the same 
concentration of dialyzed serum (Life Technologies, Inc.) was added as a replacement of FBS 
(100mL for 1 L medium).
Cytotoxicity Assays
General Procedures
In vitro cytotoxicity assay: Pancreatic cancer cells (PANC-1, BxPC-3, or Capan-2), were 
seeded in 96-well plates at a density of 23,000 cells per well and incubated in DMEM, at 37 °C, 
5% CO2 for 24 h. After rinsing with PBS, cells were subjected to the addition of NRM, NDM, or 
special media conditions. Serially diluted solutions of compounds 21 (5.5% v/v DMSO in NDM) 
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were added to the cells up to a series of concentrations of 100 μM, 50 μM, 25 μM, 12.5 μM and 
6.25 μM, followed by a 24 h incubation at 37 °C, 5% CO2. Cell morphology was monitored 
under  an  inverted  microscope.  After  washing  with  PBS,  cytotoxicity  was  assessed  by  the 
addition  of  DMEM  containing  10%  WST-8  cell  counting  reagent  (Dojindo  Molecular 
Technologies). Following a 3 h incubation at 37 °C, 5% CO2, absorbance values were measured 
with a plate reader (SpectraMax® M3 from Molecular Devices) at 450 nm, and cell viability was 
calculated using the equation:
Time Dependent Study
Instead of variable compound concentrations and constant 24 h incubation, PANC-1 cells 
were treated with and without 10µM 21 in NDM and NRM for 8, 16, 24, 48, and 72 hours. The 
absorbance of PANC-1 not treated with compound 21 in NRM after 8h incubation was defined as 
100% viability  reference,  and  the  absorbance  of  plain  DMEM was  defined  as  0% viability 
reference. Two replicate experiments were conducted, and similar results were obtained.
Medium Component Study
A total  of  11 assays for 11 different  medium conditions were prepared following the 
general cytotoxicity assay procedures. The absorbance of cancerous cells (PANC-1 or BxPC-3) 
not treated with 21 was defined 100% viability reference for each medium condition, and the 
absorbance of cancerous cells treated with 1% Triton X-100 (Sigma) was defined as 0% viability 
reference. At least three replicate experiments were conducted for each medium condition, and 
similar results were obtained.
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%cellviability= Abstest-Abs0%Abs100%-Abs0% x100%
Autophagy Time Dependent Study
Instead of variable compound concentrations and constant 24 h incubation, PANC-1 cells 
were treated with plain medium, 10µM 21, or 25µM chloroquine in NDM and NRM for 3, 7, 12, 
and 24 hours. The absorbance of PANC-1 after 0 hour incubation was defined as 100% viability 
reference,  and the absorbance of PANC-1 treated with 1% Triton X-100 was defined as 0% 
viability  reference.  Three  replicate  experiments  were  conducted,  and  similar  results  were 
obtained.
CYTO-ID Autophagy Detection Kit
Materials
Cyto-ID® Autophagy Detection kit was purchased from ENZO® Life Science Inc. The kit 
included Cyto-ID® Green Detection Reagent, rapamycin, chloroquine, and assay buffer. 
Fluorescence Microscopy
PANC-1 cells were seeded in a 8-well chamber plates at a density of 1000-5000 cells per 
well and incubated in DMEM, at 37 °C, 5% CO2 for 24 h. After rinsing with PBS, cells were 
subjected to the addition of NRM or NDM. To set the positive reference, PANC-1 cells were 
treated with different combinations of chloroquine (10, 50, and 100µM) and rapamycin (0.5, 1, 
and 2µM) for 18 hours at 37 °C, 5% CO2. To test the effect of 21 on autophagy, PANC-1 cells 
were treated with 10µM 21,  50µM chloroquine and 1µM rapamycin as positive control,  and 
combination of 21 and positive control for 20 hours at 37 °C, 5% CO2. After washing with assay 
buffer twice, cells were incubated with Cyto-ID® Green Detection Reagent (2 µL for 1 mL assay 
buffer) for 30 minutes while protected from light at 37 °C, 5% CO2. After washing with assay 
buffer twice, the plastic chamber was removed. Mounting media was added one dot per well, and 
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coverslip  was  overlaid.  The  fluorescence  images  were  taken  by  Nikon  80i  Fluorescent 
Microscope with a standard FITC filter set.
Fluorescence Microplate
PANC-1 cells were seeded in a 96-well clear bottom black microplate at a density of 
60,000 cells per well and incubated in DMEM, at 37 °C, 5% CO2 for 24 h. After rinsing with 
PBS, cells were treated with plain medium, 10µM 21, 50µM chloroquine and 1µM rapamycin as 
positive  control,  and  combination  of  21  and  positive  control  in  NRM or  NDM for  desired 
incubation time at 37 °C, 5% CO2. After washing with assay buffer twice, cells were incubated 
with Cyto-ID® Green Detection Reagent (1 µL for 1 mL assay buffer) for 30 minutes while 
protected from light at 37 °C, 5% CO2. After washing with assay buffer twice, cells were added 
with fresh assay buffer, and fluorescence values were bottom read with a fluorescence microplate 
reader (SpectraMax® M3 from Molecular Devices) with excitation at 480nm and emission at 
530nm. Fluorescence readings below the reading of background, which was cells treated with the 
same conditions but without Cyto-ID®, were removed. The reported fluorescence is the mean of 
readings subtracted by the background reading.
Western Blotting Analysis of Autophagy
Preparation of Cell Lysate
PANC-1 cells were seeded in T-75 flasks or 6-well plates at a density of 600,000 cells per 
well, and incubated in DMEM, at 37 °C, 5% CO2 for 24 h. After rinsing with PBS, cells were 
treated with plain medium, 10µM 21, 25µM chloroquine (Sigma), or 1µM wortmannin (Sigma) 
in NRM or NDM for 24 hours or desired incubation time at 37 °C, 5% CO2. Due to the short 
half-life of wortmannin, PANC-1 was incubated with wortmannin for 4 hours, then the media 
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was removed, and cells incubated in fresh NRM or NDM for the other 20 hours. Lysing solution 
was freshly made by diluting 100X HaltTM Protease Inhibitor Cocktail (Thermo Scientific) in 
cold Pierce RIPA Buffer (Thermo Scientific). After washing with cold PBS twice, cold lysing 
buffer was added 1 mL for each T-75 flask or 150 µL per well for 6-well plate, and kept on ice 
for 5 min with occasion stirring for uniform spreading of lysing buffer. Each cell lysate was 
collect with a cell  scraper and transferred into a micro-centrifuge tube, and centrifuged with 
Eppendorf Centrifuge 5804R at 14000 rpm for 15 min at 4 ºC. The protein concentrations of cell 
lysate supernatants were measured with NanoDrop 2000 Spectrophotometer (Thermo Scientific). 
Cell lysates were stored in -20 ºC in aliquots.
Western Blotting
Cell lysate supernatants containing equal amounts of protein were subjected to 4-20%  or 
any kD Mini-PROTEAN® TGX gels (Bio-Rad), after addition of Laemmli sample buffer (Bio-
Rad) and boiling for 5 min. 5 µL Precision Plus Protein WesternC Standards (Bio-Rad) or 7 µL 
Precision Plus Protein Dual Color Standards (Bio-Rad) was loaded for each gel. The running 
buffer for the TGX gels were 1X Tris/Glycine/SDS (Novex), and the gels were run at 140-180 V. 
Polyvinylidene difluoride (PVDF) membranes (Bio-Rad) were activated in methanol prior  to 













The gel was transferred at 50-70 V for 90 min in cold transferring buffer made by dissolving a 
pack of BuPH Tris-Glycine SDS Buffer (Pierce) in 200 mL methanol and 800 mL deionized 
water. The membrane was washed with washing buffer twice, then blocked in blotting buffer for 
60 min at room temperature. Washing buffer was prepared by adding 50 mL 20X Tris-buffered 
saline (dissolving 193.6 g Tris base and 640 g NaCl in 4 L deionized H2O, and adjusting pH to 
7.6), 5 mL 20% Tween20 (American Bioanalytical), and bring the volume to 1 L with deionized 
water. Blotting buffer was prepared by dissolving 2.5 g blocking reagent (Bio-Rad) in 50 mL 
washing  buffer.  The  membrane  was  then  incubated  on  shaker  with  polyclonal  LC3B/
MAP1LC3B Antibody (1:1000, Novus) for 4 hours, and GAPDH Antibody (1:3000, Rockland) 
for 1-2 hours, and optionally polyclonal p62/SQSTM1 Antibody (1:1000, Novus) for 2-3 hours, 
with  a  quick  wash  between  each  primary  antibody.  After  a  thorough  wash,  membrane  was 
incubated with Goat anti-Rabbit IgG (1:5000, Thermo) for 1h, and optionally StrepTactin-HRP 
Conjugate  (1:10000,  Bio-Rad)  for  2-4  hours.  After  another  thorough  wash,  membrane  was 
sprayed with Chemiluminescent HRP Antibody Detection Reagent (Danville Scientific Inc.) and 
left for 1 min. The blot was placed between two transparent plastic sheets, and was visualized 
with ChemiDocTM MP Imaging System (Bio-Rad).  The density of  each band of LC3-II  was 
measured using Image Lab software.  Densities were described in relation to the densities of 
GAPDH for each medium condition.
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Cyto-ID Autophagy Detection Kit with Hoechst Nuclear Stain
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Replicate Western blots for effect of 21 on LC3-I & II











GAPDH 17044.7 14883.9 10015.1 13012.7 13939.1 10827.8 10231.2 14718.9
LC3-I 20840.7 17370.6 17396.0 15296.6 10634.8 4459.3 8210.8 12904.7
LC3-I ratio to 
GAPDH 1.22 1.17 1.74 1.18 0.76 0.41 0.80 0.88
LC3-II 13895.3 10940.8 14552.3 11572.2 12224.9 8067.1 12277.2 7122.8
LC3-II ratio to 
GAPDH 0.82 0.74 1.45 0.89 0.88 0.75 1.20 0.48
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